These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies. Opie LH; Yusuf S; Kübler W Prog Cardiovasc Dis; 2000; 43(2):171-96. PubMed ID: 11014332 [TBL] [Abstract][Full Text] [Related]
4. Use of calcium channel blockers in hypertension. Conlin PR; Williams GH Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192 [TBL] [Abstract][Full Text] [Related]
6. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker. Kuti EL; Baker WL; White CM Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720 [TBL] [Abstract][Full Text] [Related]
7. Safety of calcium antagonists: more ACTION. Messerli FH; Staessen JA Am J Med; 2005 Dec; 118(12):1418-20. PubMed ID: 16378803 [No Abstract] [Full Text] [Related]
8. The calcium channel blocker debate. Owens P; O'Brien E Ir Med J; 1998; 91(5):158, 160-1. PubMed ID: 9973747 [TBL] [Abstract][Full Text] [Related]
11. Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction. Gillman MW; Ross-Degnan D; McLaughlin TJ; Gao X; Spiegelman D; Hertzmark E; Goldman L; Soumerai SB J Am Geriatr Soc; 1999 May; 47(5):512-7. PubMed ID: 10323641 [TBL] [Abstract][Full Text] [Related]
12. Calcium channel blockers: an evidence-based review. Waters D Can J Cardiol; 1997 Aug; 13(8):757-66. PubMed ID: 9284842 [TBL] [Abstract][Full Text] [Related]
13. Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients. Kloner RA; Vetrovec GW; Materson BJ; Levenstein M Am J Cardiol; 1998 Jan; 81(2):163-9. PubMed ID: 9591899 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension. Palmieri V; Devereux RB Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398 [TBL] [Abstract][Full Text] [Related]
15. Calcium channel blockers for tocolysis: a review of their role and safety following reports of serious adverse events. Oei SG Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):137-45. PubMed ID: 16567033 [TBL] [Abstract][Full Text] [Related]
16. Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR. Kojima M; Taniguchi M; Sato K; Ueda R; Dohi Y Nephron Clin Pract; 2004; 97(2):c49-53. PubMed ID: 15218330 [TBL] [Abstract][Full Text] [Related]
17. [Controversy about using calcium antagonists for treatment of coronary disease and hypertension]. Głuszek J; Pawlaczyk-Gabriel K Przegl Lek; 1997; 54(9):597-601. PubMed ID: 9501678 [TBL] [Abstract][Full Text] [Related]